Literature DB >> 21949215

Toward more accurate pan-specific MHC-peptide binding prediction: a review of current methods and tools.

Lianming Zhang1, Keiko Udaka, Hiroshi Mamitsuka, Shanfeng Zhu.   

Abstract

Binding of short antigenic peptides to major histocompatibility complex (MHC) molecules is a core step in adaptive immune response. Precise identification of MHC-restricted peptides is of great significance for understanding the mechanism of immune response and promoting the discovery of immunogenic epitopes. However, due to the extremely high MHC polymorphism and huge cost of biochemical experiments, there is no experimentally measured binding data for most MHC molecules. To address the problem of predicting peptides binding to these MHC molecules, recently computational approaches, called pan-specific methods, have received keen interest. Pan-specific methods make use of experimentally obtained binding data of multiple alleles, by which binding peptides (binders) of not only these alleles but also those alleles with no known binders can be predicted. To investigate the possibility of further improvement in performance and usability of pan-specific methods, this article extensively reviews existing pan-specific methods and their web servers. We first present a general framework of pan-specific methods. Then, the strategies and performance as well as utilities of web servers are compared. Finally, we discuss the future direction to improve pan-specific methods for MHC-peptide binding prediction.

Mesh:

Substances:

Year:  2011        PMID: 21949215     DOI: 10.1093/bib/bbr060

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  58 in total

1.  Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy?

Authors:  Claus Lundegaard; Ole Lund; Morten Nielsen
Journal:  Expert Rev Vaccines       Date:  2012-01       Impact factor: 5.217

2.  Improved methods for predicting peptide binding affinity to MHC class II molecules.

Authors:  Kamilla Kjaergaard Jensen; Massimo Andreatta; Paolo Marcatili; Søren Buus; Jason A Greenbaum; Zhen Yan; Alessandro Sette; Bjoern Peters; Morten Nielsen
Journal:  Immunology       Date:  2018-02-06       Impact factor: 7.397

3.  Learning sequence determinants of protein:protein interaction specificity with sparse graphical models.

Authors:  Hetunandan Kamisetty; Bornika Ghosh; Christopher James Langmead; Chris Bailey-Kellogg
Journal:  J Comput Biol       Date:  2015-05-14       Impact factor: 1.479

4.  Automated benchmarking of peptide-MHC class I binding predictions.

Authors:  Thomas Trolle; Imir G Metushi; Jason A Greenbaum; Yohan Kim; John Sidney; Ole Lund; Alessandro Sette; Bjoern Peters; Morten Nielsen
Journal:  Bioinformatics       Date:  2015-02-25       Impact factor: 6.937

5.  Prediction of peptide binding to a major histocompatibility complex class I molecule based on docking simulation.

Authors:  Takeshi Ishikawa
Journal:  J Comput Aided Mol Des       Date:  2016-09-13       Impact factor: 3.686

6.  Improved pan-specific MHC class I peptide-binding predictions using a novel representation of the MHC-binding cleft environment.

Authors:  S Carrasco Pro; M Zimic; M Nielsen
Journal:  Tissue Antigens       Date:  2014-02

7.  TepiTool: A Pipeline for Computational Prediction of T Cell Epitope Candidates.

Authors:  Sinu Paul; John Sidney; Alessandro Sette; Bjoern Peters
Journal:  Curr Protoc Immunol       Date:  2016-08-01

8.  A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction.

Authors:  Shutao Mei; Fuyi Li; André Leier; Tatiana T Marquez-Lago; Kailin Giam; Nathan P Croft; Tatsuya Akutsu; A Ian Smith; Jian Li; Jamie Rossjohn; Anthony W Purcell; Jiangning Song
Journal:  Brief Bioinform       Date:  2020-07-15       Impact factor: 11.622

9.  Monoclonal antibody preparation and expression profile analysis of a novel hepatoma associated gene.

Authors:  Yanhong Liu; Jie Song; Yuehui Li; Yanjie Zhao; Qiang Ju; Guohua Zhou; Guancheng Li
Journal:  Pathol Oncol Res       Date:  2013-11-09       Impact factor: 3.201

Review 10.  Tumor neoantigens: building a framework for personalized cancer immunotherapy.

Authors:  Matthew M Gubin; Maxim N Artyomov; Elaine R Mardis; Robert D Schreiber
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.